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Abstract
A case ofmalignantpleural mesothelioma discovered becauseofa chest wall metastasiswhichdeveloped
over a previous pleural drainage site is presented. Imaging findings at sonography, contrast enhanced
computed tomography and fluorodeoxyglucose - positron emission tomography are shown.
Case presentation
A 64-year-old Caucasian male from Italy complained of
onset of thoracic pain which gradually developed after
undergoingaleft-sidedpleuraleffusiondrainage9months
earlier; at that time he was dismissed from the hospital
without any further investigation since pleural fluid
cytologic analysis did not show malignant cells.
Because of progressive worsening of his symptoms he
returned to medical attention. Complete cutaneous heal-
ing of the drainage insertion site was seen at physical
examination which also revealed tenderness of chest wall
exacerbated by digitopression.
Ultrasound of the chest wall was performed showing an
inhomogeneous hypoechoic subcutaneous soft tissue
lesion with ill-defined borders (Figure 1a) corresponding
to the prior drainage site. Pleural calcifications and
effusion were also seen (Figure 1b) and further imaging
was recommended.
A contrast enhanced chest multidetector CT showed left
hemithorax volume loss with concentric nodular pleural
thickening (Figure 2a) involving the parietal, mediastinal,
diaphragmatic pleural surfaces as well as the interlobar
fissure. A subcutaneous enhancing soft tissue plaque in the
left latissimus dorsi muscle (Figure 2b, c) corresponding to
the sonographic finding was also noticed. Thinner scattered
partially calcific pleural plaques were seen on the right
hemithorax. No mediastinal adenomegalies were present.
An FDG-PET scan was performed showing increased left
pleural and chest wall (Figure 3) radiotracer uptake whilst
no hypermetobolism was noticed in right pleural plaques.
Imaging findings were consistent with drainage tract
metastasis from underlying malignant mesothelioma
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sure (the patient was a former plumber).
CT-guided biopsy subsequently confirmed the diagnostic
impressions.
The patient was considered unresectable because of the
extensive diaphragmatic involvement and was then
referred to an oncologist who treated him with radio-
therapy, chemotherapy and palliative care. He passed
away 1 year later because of respiratory insufficiency.
Discussion
Malignant pleural mesothelioma (MPM) is a locally
aggressive tumor of the pleura frequently associated to a
prior asbestos exposure, which has been estimated to be
responsible of about 70-90% of cases [1].
Asbestos induces DNA damage and mutations in mesothe-
lial cells. The carcinogenic effect may be the result of direct
effect of asbestos fibers on mitotic spindle of cells
disrupting mitosis or be secondary to formation of reactive
oxygen species [2].
Other risk factors include previous chest radiation therapy,
exposure to Thorotrast contrast medium and SV40 virus
infection [3].
Figure 1. Chest wall ultrasounds showing an ill-defined
subcutaneous lesion with inhomogeneous hypoechoic
structure (a). Hyperechoic linear thickening of pleural surface
consistent with calcified pleural plaques are seen (b).
Figure 2. Contrast enhanced CT of the chest showing the
pathological circumferential pleural thickening (a) and the
chest wall tract metastasis (b, c).
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that may lead to encasement of the lungin advanced stages.
MPM is locally aggressive, with frequent invasion of the
chest wall, mediastinum, and diaphragm. Contraction of
the affected hemithorax with associated ipsilateral mediast-
inalshiftandhemidiaphragmaticelevationmaybeseen[4].
Howeverafewcasesofcontralateralmediastinalshiftdueto
mesothelioma have been also reported in the literature [5].
Distant metastases are uncommon [3].
MPM is associated with a poor median survival, ranging
from 4 to 18 months. Treatment is difficult because of the
natural resistance of this tumor-entity and single modality
therapy gave disappointing results. Multimodality treat-
ment approaches involving surgery with radiation and
chemotherapy, seem to be promising in a selected group
of MPM patients [3]. Conventional chest radiography
usually reveals pleural effusion and/or nodular pleural
thickening; however early stages of disease may be
overlooked since pleural fluid may hide underlying
pleural thickening [4]. CT is superior to radiography for
the identification of early abnormalities in patients with
MPM and allows better evaluation of the morphology and
extent of the pathology [4]. Key CT findings that suggest
MPM include unilateral pleural effusion, nodular pleural
thickening, and interlobar fissure thickening. Growth
typically leads to tumoral encasement of the lung with a
rindlike appearance. Calcified pleural plaques are found at
CT in approximately 20% of patients [6].
Magnetic resonance imaging can allow improved detec-
tion of tumor extension, especially to the chest wall and
diaphragm but in the majority of the cases CT and MRI are
nearly equivalent and provide similar diagnostic and
staging information [7].
FDG-PET is useful in the staging and preoperative
evaluation of MPM because of its increased accuracy for
detecting mediastinal nodal metastases and its ability to
determine the most appropriate biopsy sites [8].
Ultrasounds may show pleural effusions, areas of pleural
thickening, calcifications and may be used to assess chest
wall invasion with higher sensitivitythan CT;drawbacks of
sonography are lack of panoramicity and poor acoustic
windows in certain regions of the thorax like the
subscapular and paraspinal areas [9].
It’s important to remark that pleural abnormalities seen in
MPM are not pathognomonic and may be encountered in
a variety of conditions like infections (tuberculosis, fungal,
actynomicosis), fibrothorax, empyema and metastatic
disease to the pleura (most frequently adenocarcinomas
arising in the lungs, breast, ovaries and stomach) as well in
asbestos-related pleural fibrosis [4].
A tissue diagnosis is therefore required. Unfortunately it is
not uncommon to have negative cytology after pleural
drainage as it happened in the initial evaluation of our
patient; diagnostic yield of pleural fluid cytology may
indeed be as low as 20-30% [10].
For this reasons an histological specimen by means of
core-biopsies techniques is often necessary to achieve a
correct diagnosis [3]. MPM may however complicate these
procedures and develop subcutaneous tumor deposits via
needle biopsy tracks, surgical scars, and chest tube tracts
[11]. It has been estimated that up to 15% of patient with
MPM develop chest wall metastases along percutaneous
biopsy tracts and drainage canals after aspiration of
large effusions. Chest wall metastases rates are even higher
(40%) after operative or thoracoscopic excision of biopsy
specimens [12,13].
These metastases may cause important pain and discom-
fort to the patient. For this reason prophylactic drain site
radiotherapy in MPM, has been advocated in the past to
reduce the incidence of tumour seeding [14] and has been
diffusely adopted worldwide; however there’s actually
controversy about the effectiveness of this treatment since
more recent randomized clinical trials showed no statis-
tically significant difference in occurrence of tract metas-
tases in patients treated with radiotherapy and control
groups [15]. Despite these controversies, the possibility of
a tract metastases should be kept in mind and warn
physicians when a patient with known mesothelioma or
previous asbestos exposure develops chest pain over
previous pleural intervention sites.
Figure 3. FDG-PET showing striking hypermetobolism
in the pleural cavity and chest wall lesions.
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